Chronic migraines and recurring headaches can significantly affect work, family life, concentration, and emotional resilience. Our Istanbul consultations help international patients understand whether regenerative medicine in Turkey may support a broader strategy for chronic headache management.
How treatment is delivered
For neurological conditions the route matters as much as the product. Your physician may combine intrathecal, intravenous and intranasal delivery in a single program, chosen after reviewing your history, imaging and goals.
A physician places the preparation into the cerebrospinal fluid through a fine needle at the lower back, under sterile conditions. That fluid surrounds the spinal cord and the brain, which is why this route is central to these programs.
Stem cells and exosomes are given as a calm, monitored infusion. The circulation carries them through the body, where they are studied for their signalling and immune-modulating effects.
Exosomes are also given as a nasal spray. The route is studied because the olfactory nerve offers a short pathway toward the brain, and it needs no needle at all.
From context to evidence
Explore the subject, the proposed biology and the questions that connect research to an informed medical review. Illustrations are conceptual and do not depict a treatment result.
01 / Context
A useful review of migraines & headaches begins with the individual: the diagnosis, current care and what matters in daily life. The illustration provides a visual introduction to the topic.
Which findings relate to this diagnosis, and how will neurological function be assessed?
02 / Cell signaling
Researchers study soluble factors and extracellular vesicles released by stromal cells, including how they interact with other cells. A biological mechanism observed in a laboratory does not establish a treatment benefit in people.
What evidence addresses delivery, persistence and effects in the intended nervous-system tissue?
03 / Evidence
Read the human-study results for the proposed intervention. Discuss who was studied, the comparison group, meaningful outcomes, adverse events and follow-up duration. Agree how benefit, no change and complications would be assessed.
What are the alternatives, uncertainties, costs and follow-up arrangements for this proposal?
TurkeyStemcell approaches migraines & headaches with a regenerative medicine strategy focused on patient selection, medical review, and realistic planning in Istanbul, Turkey. Depending on the condition and the wider protocol, supportive goals may include the following:
Our programs are designed for neurology patients who want a medically professional consultation before committing to travel. Candidate review may include medical records, imaging, current medications, functional limitations, and broader treatment goals.
At TurkeyStemcell we approach migraines & headaches with clinical honesty. Mesenchymal stem cell therapy and exosome therapy are best understood as supportive regenerative options — not guaranteed cures. Even when the underlying biology is promising, outcomes are individual and depend on a combination of factors that we review before accepting any patient for treatment in Istanbul.
Realistic outcomes vary based on the specific diagnosis, severity and chronicity of the condition, the patient's age, the level of underlying inflammation or tissue damage, lifestyle factors, comorbidities, current medications, and overall health. For this reason every candidate is reviewed individually during the medical assessment and consultation stage, and treatment is only recommended when the team believes a meaningful supportive benefit is plausible.
Stem cell and exosome procedures are generally well tolerated, but patients should be aware of the realistic side-effect profile so expectations are set honestly. Depending on the administration route used in the protocol, the following short-term effects may occur:
Serious adverse events are uncommon when treatment is delivered under medical supervision with properly screened cell products, but no medical procedure is risk-free. Regenerative therapy should always be understood as part of a broader care plan — it does not replace emergency care, prescribed medication, physiotherapy, or specialist follow-up where those are clinically necessary. Patients are encouraged to maintain ongoing care with their own physician and to read our patient journey, clinical studies, and FAQ resources before booking, so decisions are made with realistic, well-informed expectations.
It is also important to be transparent about what regenerative medicine cannot do. Stem cell and exosome therapy do not reverse advanced structural damage, do not regrow lost limbs or fully destroyed organs, and do not replace evidence-based interventions such as surgery, dialysis, oncology care, or critical-care medication when those are clearly indicated. Treatment for migraines & headaches is offered when the team believes the supportive biological mechanisms — such as modulation of inflammation, immune signalling, and tissue micro-environment — may meaningfully complement the patient's existing care, not when it is being used as a last-resort substitute for proven medicine.
Patients who are accepted for treatment receive written guidance well before travel so the visit runs smoothly and the medical team has the clinical context it needs. Preparation typically includes gathering recent medical records, imaging, and laboratory results relevant to migraines & headaches; sharing a current medication list (including supplements and blood thinners); and confirming any allergies or prior adverse reactions. We recommend arriving well-rested, well-hydrated, and with realistic personal goals discussed in advance with family or your home physician. Logistics such as airport transfers, hotel coordination near the clinic, translation support, and the daily schedule are organised by our international patient team — full details are summarised on our patient journey page and answered in the FAQ.
Regenerative responses are biological, not pharmacological, so improvements (when they occur) tend to develop gradually rather than overnight. Many patients report the first subtle changes — for example reduced inflammatory discomfort, improved sleep, or modestly better function — within the first few weeks, with the more meaningful supportive effects often becoming clearer over a 2–6 month window as the body's repair, anti-inflammatory, and signalling pathways respond. Some patients respond strongly, some respond modestly, and some do not respond as hoped; this honest range is consistent with the published clinical studies and is part of why candidate selection matters so much. After your visit, our team stays in contact for structured follow-up, and we encourage patients to continue their regular care with their home physician throughout the response window. If you would like a personalised assessment of whether treatment is appropriate for your specific situation, the next step is a medical consultation.
An outline for planning care. Timing depends on the proposed intervention and individual needs; these stages do not predict biological changes or a treatment result.
Comprehensive in-person consultation with Uzm. Dr. Cihan Bolat. Baseline imaging review, inflammatory blood markers, and vital signs confirmation.
Confirm the proposed product, procedure, setting, quality records and observation plan with the treating physician before proceeding.
Follow the individualized aftercare plan. Know whom to contact about new symptoms, complications or questions, and record changes without assuming they are treatment effects.
Agree review dates and meaningful outcome measures. Discuss benefit, no change or deterioration, and coordinate ongoing care with your usual medical team.
When available, prior imaging and neurology records are helpful because they strengthen clinical review and safety planning.
Yes, especially where patients are exploring therapies aimed at signaling support within neurological care pathways.
Regenerative medicine is only as safe as the lab, the licensing, and the documentation behind it. Here is the regulatory and quality stack every TurkeyStemcell patient is treated under.
Clinic and procedure protocols authorized under the Republic of Türkiye Ministry of Health regulatory framework for advanced cellular therapies.
Wharton's Jelly–derived MSCs prepared in a Good Manufacturing Practice (GMP) facility with documented release criteria and chain-of-custody.
Quality management certified to ISO 9001 — every patient pathway, from intake to follow-up, follows a documented and audited process.
Each batch is tested for viability, identity (CD73/CD90/CD105+, CD34/CD45−), sterility, endotoxin, and mycoplasma before release.
Tissue is sourced from full-term, consented C-section donations following Turkish bioethics and international Declaration of Helsinki standards.
Multilingual coordination, KVKK/GDPR-aligned data handling, and post-treatment follow-up at 1, 3, 6 and 12 months for every international patient.
Documentation, batch release certificates, and licensing references are available on request during your consultation.
Stem cell therapy and exosome therapy should be understood as medically reviewed regenerative medicine options, not guaranteed cures. Treatment suitability, likely benefit, and risk profile vary by diagnosis, severity, age, comorbidities, and clinical history. Ongoing care with your regular physician remains important.
Schedule a free, no-obligation consultation with our regenerative medicine specialists. We treat patients from over 40 countries.
Or call directly: +90 534 856 92 92
Optional analytics is off until you choose.
May we use Google Analytics cookies to count interactions such as consultation requests and contact-button clicks? Your choice is optional and does not affect access to our services. You can change it here at any time. Read our privacy policy.
